Pfizer

Pfizer is a pharmaceutical company for medicines and vaccines, and that is where its name carries real weight. By our assessment, it is especially strong when a drug has to be developed, tested and shipped at industrial scale, because that is the world it knows best. The downside is that this is a research-heavy business with long timelines, patent pressure and the constant risk that one product will not carry the next. In practice, Pfizer feels like a company of pipelines, approvals and large manufacturing systems rather than of consumer-facing polish. Against smaller biotech firms, it has more breadth and more reach; against generic-drug makers, it is much more dependent on branded research. It is a sensible name for readers looking at large pharma with vaccine and prescription-drug exposure, and not the one to expect simple, quick wins from.